<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="52093">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02087930</url>
  </required_header>
  <id_info>
    <org_study_id>02/14</org_study_id>
    <nct_id>NCT02087930</nct_id>
  </id_info>
  <brief_title>Microbiota as Potential Target for Food Allergy</brief_title>
  <official_title>Microbiota as Potential Target for Innovative Preventive and Therapeutic Strategies for Food Allergy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <authority>Italy: Ethics Commitee &quot;Carlo Romano&quot;</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Food allergy (FA) derives from a dysregulation of oral tolerance mechanisms. Studies suggest
      a crucial role for enteric microflora in oral tolerance development. An altered composition
      of intestinal microflora results in an unbalanced local and systemic immune response to food
      allergens. There are qualitative and quantitative differences in gut microbiota composition
      in children with food allergy. These findings support the concept that specific beneficial
      bacteria from human intestinal microflora, designated probiotics, could restore intestinal
      microflora homeostasis and prevent or treat FA. The investigators demonstrated that it is
      possible to stimulate oral tolerance acquisition in children with cow's milk allergy using
      the most studied probiotic in the pediatric field, Lactobacillus rhamnosus GG (LGG). The
      main study aim is to identify an innovative strategy to induce oral tolerance acquisition by
      a selective manipulation of intestinal microflora.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Composition and localization of gut microbiota elicited by the administration of Lactobacillus rhamnosus GG in children with food allergy.</measure>
    <time_frame>Change from baseline at 6 and 12 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treg expression and function at different intestinal levels induced by the administration of Lactobacillus rhamnosus GG and the role of selected miRNA.</measure>
    <time_frame>Change from baseline at 6 and 12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Butyrate levels in children with cow's milk allergy</measure>
    <time_frame>Change from baseline at 6 and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>-Food Allergy</condition>
  <arm_group>
    <arm_group_label>EHCF + LGG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Extensively hydrolyzed casein formula plus Lactobacillus GG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EHCF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Extensively hydrolyzed casein formula</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>EHCF + LGG</intervention_name>
    <description>EXtensively hydolyzed casein formula plus Lactobacillus GG</description>
    <arm_group_label>EHCF + LGG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>EHCF</intervention_name>
    <arm_group_label>EHCF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children with cow's milk allergy

          -  age 0-60 months

        Exclusion Criteria:

          -  concomitant chronic systemic diseases

          -  congenital cardiac defects

          -  active tuberculosis

          -  autoimmune diseases

          -  immunodeficiency

          -  chronic inflammatory bowel diseases

          -  celiac disease, cystic fibrosis

          -  metabolic diseases

          -  malignancy

          -  chronic pulmonary diseases

          -  malformations of the gastrointestinal tract

          -  suspected eosinophilic esophagitis or eosinophilic enterocolitis

          -  suspected food-protein-induced enterocolitis syndrome.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>60 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Naples Federico II</name>
      <address>
        <city>Naples</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Berni Canani</last_name>
      <phone>0817462680</phone>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 13, 2014</lastchanged_date>
  <firstreceived_date>March 10, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>Roberto Berni Canani</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Food Hypersensitivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
